Helpdesk

Sales contact

Home > Immuno-Inflammation

Immuno-Inflammation

Article

Implementing electronic Patient Reported Outcomes (ePROs) in Arthritis Clinical Research: Importance, benefits, and management for incorporating ePROs

Arthritis is a general term categorized by acute or chronic inflammation of the joints. Arthritis may cause a variety of symptoms, most commonly pain, stiffness, decreased range of motion, and...

Case study

Immunology Case Study

Immuno-Inflammation

Immunology studies present specific challenges: their eCOA build can be complex, site staff must play a key role, and study...

Case study

Kayentis supports the 1st personalized immunotherapy treatment approved by both FDA & EMA

Immuno-Inflammation

Acute Lymphoblastic or Lymphoid Leukemia (ALL) is a cancer of the lymphocytes that can result in serious complications such as...

Subscribe to our newsletter

Rare disease clinical research: it is time to tackle what...

Biotech and eCOA vendor: A shared mindset

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA